Advertisement

Factors Affecting Clinical Progression and Mortality

  • J. A. Dormandy

Abstract

Although much has been published on the surgical treatment of leg ischaemia, relatively little is known about claudication in general and the fate of the majority of patients with chronic leg ischaemia who never present to a specialist (usually surgical) department. In a review of the literature on the fate of the claudicant (Dormandy et al. 1989), it was concluded that on the scanty evidence available the prevalence of intermittent claudication in men below the age of 50 is approximately 1% to 1.5%, rising rapidly with age to over 5% in older men. In the few reports where men and women were studied at an early stage of the disease, their ratio was less than 2:1. However, in most studies looking at a more advanced stage, the ratio of men to women is much higher, ranging from 3:1 to 13:1. This would suggest that the prognosis of the local disease in women is much better than in men, a view supported by the recent PACK (Prevention of Atherosclerotic Complications by Ketanserin) analysis (Dormandy and Murray 1991).

Keywords

Intermittent Claudication Major Amputation Amputation Rate Pack Study Atherosclerotic Complication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Biland L, Da Silva A, Zemp E, Widmer LK (1985) Occlusive peripheral artery disease (OPAD). Mortality and risk profile. In: Proceedings of the 13th International Congress of Angiology, Athens, 9–14th June, 1985Google Scholar
  2. Bloor K (1961) Natural history of arteriosclerosis of the lower extremities. Ann R Coll Surg Engl 28:36–51PubMedGoogle Scholar
  3. Cronenwett JL, Warner KG, Zelenock GB et al. (1984) Intermittent claudication. Arch Surg 119:430–6PubMedGoogle Scholar
  4. Dormandy J, Mahir M, Ascady G et al. (1989) Fate of the patient with chronic leg ischaemia. J Cardiovasc Surg 30:50–7Google Scholar
  5. Dormandy JA, Murray GD (1991) The fate of the claudicant — a prospective study of 1969 claudicants. Eur J Vase Surg 5:131–3CrossRefGoogle Scholar
  6. Dormandy JA, Thomas PRS (1988) What is the natural history of a critically ischaemic patient with and without his leg? In: Greenhalgh RM, Jamieson CW, Nicolaides AN (eds) Limb salvage and amputation for vascular disease. WB Saunders, Philadelphia, pp. 11–26Google Scholar
  7. Ernst E, Hammerschmidt DE, Bagge U et al. (1987) Leukocytes and the risk of ischemic diseases. JAMA 257:2318–24PubMedCrossRefGoogle Scholar
  8. Gilliland EL, Llewellyn CD, Goss DE, Lewis JD. The morbidity and mortality of stable claudicants — results of five year follow-up. Presented at 2nd International Vascular Symposium, London, September 1986Google Scholar
  9. Hughson WG, Mann JI, Garrod A (1978) Intermittent claudication: prevalence and risk factors. Br Med J i: 1379–81CrossRefGoogle Scholar
  10. Jelnes A, Gaardsting O, Hougaard Jensen K et al. (1986) Fate in intermittent claudication: outcome and risk factors. Br Med J 293:1137–40CrossRefGoogle Scholar
  11. Kannel WB, McGee DL (1985) Update on some epidemiological features of intermittent claudication. J Am Geriatr Soc 33:13–18PubMedGoogle Scholar
  12. Most RS, Sinnock P (1983) The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 6:87–91PubMedCrossRefGoogle Scholar
  13. PACK Claudication Substudy Investigators (1989) Randomized placebo-controlled, double-blind trial of ketanserin in claudicants. Circulation 80:1544–8CrossRefGoogle Scholar
  14. Prevention of Atherosclerotic Complications with Ketanserin Trial Group (1989) Prevention of atherosclerotic complications: controlled trial with ketanserin. Br Med J 298:424–31CrossRefGoogle Scholar
  15. Second European Consensus Document on Criticial Leg Ischaemia. Circulation 1991 (in press)Google Scholar
  16. Smith G Davey, Shipley MJ, Rose G (1990) Intermittent claudication, heart disease risk factors, and mortality: the Whitehall Study. Circulation 82:1926–31Google Scholar
  17. Widmer LK, Biland L, Da Silva A (1985) Risk profile and occlusive peripheral artery disease (OPAD). In: Proceedings of the 13th International Congress of Angiology, Athens 9–14 June, 1985Google Scholar

Copyright information

© Springer-Verlag London Limited 1991

Authors and Affiliations

  • J. A. Dormandy

There are no affiliations available

Personalised recommendations